-
FIFA boss Infantino faces questions on eve of World Cup
-
Iran attacks US bases in Jordan and Bahrain
-
Tech leads Asia losses as rollercoaster week rumbles on
-
Belfast stabbing suspect due in court after night of violence
-
Saudi's new national carrier gets off ground despite war, delays
-
Eddie Jones eyes Mourinho-like laundry stunt to escape ban
-
Bollywood's Imtiaz Ali bets on Gen Z thirst for love
-
Messi plushies see roaring trade as China firms get World Cup boost
-
Messi sparkles on return as Somali referee says World Cup dream over
-
Iran, US trade blows as Middle East peace deal draws no nearer
-
Salt: integral ingredient of sumo stars' art
-
Staal shines as Carolina beat Vegas 5-3 to level Stanley Cup Final
-
Messi scores on injury return as Argentina beat Iceland in World Cup warm-up
-
Art, maths and killing: Ukraine drone chief's formula to stop Russia
-
Tech leads Asia losses, oil rises as rollercoaster week rumbles on
-
Messi set to return as Somali referee says World Cup dream over
-
Former Wallabies skipper Wright signs for Welsh club Ospreys
-
Pope to bless Barcelona's Sagrada Familia, world's tallest church
-
Emotional World Cup return to Mexico for South Africa coach Broos
-
Bill Gates faces questioning in US Congress over Epstein ties
-
'The Donald of Dubai': property tycoon seeks to become data king
-
PGA Tour to co-sanction Australian Open in global push
-
Elon Musk, after DOGE and politics, bets on SpaceX IPO
-
Saudis in World Cup spotlight after $2bn spending spree
-
Mexico doubles down on security before 2026 World Cup
-
US must not be 'too honest' at World Cup, says Roldan
-
Italian astronaut to pilot Artemis III mission
-
North Korea says Xi's visit produced 'far-reaching blueprint' for ties
-
Benfica say farewell to Mourinho as Real Madrid return nears
-
Protesters torch buildings and vehicles, block roads over Belfast stabbing
-
US strikes Iran after Apache helicopter downing
-
Threats to US lawmakers spiked after Meta eased moderation: watchdog
-
Nick Reiner seeks trust fund money for parent murder defense
-
Spain, France qualify for 2027 Women's World Cup as England wait
-
Protesters torch building and vehicles, block roads over Belfast stabbing
-
A woman in charge of the UN? Candidates feel it's about time
-
US tech shares resume sell-off while oil prices retreat
-
Protesters block road to Mexican World Cup stadium
-
White House World Cup chief defends visa ban for Somali referee, Iranians
-
Serena back in the groove on triumphant return to tennis
-
'It doesn't matter': US star Reyna looks past World Cup scandal
-
Somali referee says World Cup 'dream' ruined
-
Knicks ready to 'throw the first punch' in NBA Finals
-
'Beaten to death': the grim toll of Ecuador's security crackdown
-
Anthropic opens most powerful AI model to public with safeguards
-
Serena Williams makes winning return in Queen's Club doubles
-
Trump vows response after Iran shoots down US helicopter
-
Real Madrid's 150 mn euros bid for Atletico's Alvarez rejected
-
Spurs handling physicality of Knicks and New York hostility
-
Peru election chief tells AFP count could take two weeks
Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
Z.AlNajjar--SF-PST